CompletedInterventionalNot ApplicableUpdated May 25, 2022
Buteyko Based Remedial Breathing Therapy With Children With Asthma | NCT02140086 | Trialant
CompletedInterventionalNot ApplicableUpdated Mar 2, 2016
Buteyko Based Remedial Breathing Therapy With Children With Asthma
ClinicalTrials.gov ID
NCT02140086
Lead Sponsor
ARCIM Institute Academic Research in Complementary and Integrative MedicineOTHER
Overall Status
Completed
Study Type
Interventional
Phase
Not Applicable
Enrollment
32Actual
Last Update Posted
Mar 2, 2016Estimated
Start Date
Jan 2014
Primary Completion Date
Nov 2014Actual
Completion Date
Nov 2014Actual
Brief Summary
A randomized, controlled trial to investigate the effects of a buteyko based remedial breathing therapy on children with asthma regarding to their symptoms, use of medication and lung function tests.
Asthma
Buteyko based Remedial Breathing Therapy
Ages Eligible for Study
Child (0-17)
Sexes Eligible for Study
All
Accepts Healthy Volunteers
Yes
Eligibility Criteria
Inclusion Criteria:
signed informed consent of the parents
age 6- 15 years
information and consent of the consulting doctor
levels of asthma therapy 1-3
Exclusion Criteria:
participation in another study
Primary Purpose
Treatment
Allocation
Randomized
Interventional Model
Crossover Assignment
Masking
None (Open Label)
No central contacts
There are no central contacts for this study.
Filderklinik
Filderstadt, Baden-Wurttemberg 70794, Germany
Lead Sponsor
ARCIM Institute Academic Research in Complementary and Integrative MedicineOTHER